Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41593 | 1.00 | — | — | |
| SCHEMBL2342421 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2347672 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2345704 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2348460 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2345604 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2350013 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL2350051 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL332580 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TRPA1ESR2SMN1; SMN2LMNA | |
| SCHEMBL353978 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756126-B1 | PROCESS FOR THE ALKYLATION OF PHOSPHORUS-CONTAINING COMPOUNDS | ICL IP AMERICA INC (US) | 2012-02-08 | — | — | EP | claimed |
| US-8097747-B2 | Process for the alkylation of phosphorus-containing compounds | ICL-IP America Inc (US) | 2012-01-17 | — | — | US | claimed |
| US-20090054675-A1 | Process for the alkylation of phosphorus-containing compounds | SUPRESTA LLCC (US) | 2009-02-26 | — | — | US | claimed |
| JP-2007534685-A | — | — | 2007-11-29 | — | — | JP | claimed |
| EP-1756126-A1 | PROCESS FOR THE ALKYLATION OF PHOSPHORUS-CONTAINING COMPOUNDS | Supresta LLC (US) | 2007-02-28 | — | — | EP | claimed |
| WO-2005105818-A1 | PROCESS FOR THE ALKYLATION OF PHOSPHORUS-CONTAINING COMPOUNDS | SUPRESTA LLC (US) | 2005-11-10 | — | — | WO | claimed |
| EP-0589446-B1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BOEHRINGER INGELHEIM CA LTD (CA) | 1997-09-03 | — | — | EP | claimed |
| US-5565476-A | RENIN INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND HYPERTENSION | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-10-15 | — | — | US | claimed |
| US-5554634-A | HYPOTENSIVE | BIO-MEGA BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1996-09-10 | — | — | US | claimed |
| EP-0589446-A1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-03-30 | — | — | EP | claimed |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2025-06-19 | — | — | US | disclosed |
| WO-2025094418-A1 | COATING COMPOSITION | 大日本塗料株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2025003023-A1 | METHOD FOR PRODUCING A CARBOXYLIC ACID | EVONIK OPERATIONS GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| US-12180217-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| EP-0589446-A1 | N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1994-03-30 | — | — | EP | disclosed |
| EP-0386940-A1 | 6-Beta-(alpha-etherified oxymino)-acyl amino penicillins | BEECHAM GROUP PLC (GB) | 1990-09-12 | — | — | EP | disclosed |
| US-4652670-A | Cycloalkyl esters of mercaptoalkanoic acids | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1987-03-24 | — | — | US | disclosed |
| US-4590082-A | FOR FOODS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-05-20 | — | — | US | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12180217-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TRPA1 3721/4885ESR2 3415/4885 |
| US-20090054675-A1 | Process for the alkylation of phosphorus-containing compounds | PHOSPHO1, INPP5D, INPPL1 | ALDH1A1 4497/4885TRPA1 3787/4885ESR2 3112/4885 |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TRPA1 3721/4885ESR2 3415/4885 |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TRPA1 3721/4885ESR2 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.